Biomarker-Defined Subsets of Common Diseases: Policy and Economic Implications of Orphan Drug Act Coverage.

by Aaron S Kesselheim, Carolyn L Treasure, Steven Joffe
Published 2017-01-01

Historical trends in health care-related financial holdings among members of Congress.

by Matthew S McCoy, Matthew Bonci, Steven Joffe, Genevieve P Kanter
Published 2021-01-01

Beyond financial conflicts of interest: Institutional oversight of faculty consulting agreements at schools of medicine and public health.

by Michelle M Mello, Lindsey Murtagh, Steven Joffe, Patrick L Taylor, Yelena Greenberg, Eric G Campbell
Published 2018-01-01

Willingness to participate in pragmatic dialysis trials: the importance of physician decisional autonomy and consent approach

by Katherine R. Courtright, Scott D. Halpern, Steven Joffe, Susan S. Ellenberg, Jason Karlawish, Vanessa Madden, Nicole B. Gabler, Stephanie Szymanski, Kuldeep N. Yadav, Laura M. Dember
Published 2017-10-01

Clinical trials and medical care: defining the therapeutic misconception.

by Gail E Henderson, Larry R Churchill, Arlene M Davis, Michele M Easter, Christine Grady, Steven Joffe, Nancy Kass, Nancy M P King, Charles W Lidz, Franklin G Miller, Daniel K Nelson, Jeffrey Peppercorn, Barbra Bluestone Rothschild, Pamela Sankar, Benjamin S Wilfond, Catherine R Zimmer
Published 2007-11-01

Pediatric reporting of genomic results study (PROGRESS): a mixed-methods, longitudinal, observational cohort study protocol to explore disclosure of actionable adult- and pediatric...

by Juliann M. Savatt, Jennifer K. Wagner, Steven Joffe, Alanna Kulchak Rahm, Marc S. Williams, Angela R. Bradbury, F. Daniel Davis, Julie Hergenrather, Yirui Hu, Melissa A. Kelly, H. Lester Kirchner, Michelle N. Meyer, Jessica Mozersky, Sean M. O’Dell, Josie Pervola, Andrea Seeley, Amy C. Sturm, Adam H. Buchanan
Published 2020-05-01